Delivery Order SPE2DB22D3010-SPE2DB25FP1RM
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $5,970.51 and is a Firm Fixed Price Delivery Order. The contract provides for the delivery of "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML", a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $1,038.35, is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is a Delivery Order valued at $2,593.71 for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.0.5ML, a pharmaceutical product. The contract has a period of performance through September 12, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen, through its Corporate Office Division, is responsible for fulfilling this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical supplies. The $28,370.99 firm fixed price delivery order contract has a completion date of May 30, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a potential value of $42,513.76. It is a firm fixed price delivery order contract with a completion date of February 2, 2024. Amerisourcebergen Drug Corp, as the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The delivery order has a ceiling value of $3,999.58 and a firm fixed price pricing type. The award is not associated with any set-aside requirements. The contract is for the delivery of pharmaceutical products, specifically "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML", to support military treatment programs and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,394.30 and is a Firm Fixed Price Delivery Order, running through January 28, 2025. The contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, the prime contractor, is a...
This federal contract award, valued at $5,183.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" medical products. It has a firm fixed price pricing type and an ultimate completion date of May 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,523.36, is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The contract is a Firm Fixed Price Delivery Order with a completion date of March 5, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,256.24, is a delivery order for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.S ML medical products. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...